Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1122 | 2742 | 39.0 | 80% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BRADYKININ | Author keyword | 234 | 25% | 30% | 810 |
2 | B 1 RECEPTOR | Author keyword | 116 | 92% | 2% | 46 |
3 | BRADYKININ B 1 RECEPTOR | Author keyword | 109 | 92% | 2% | 44 |
4 | B 2 RECEPTOR | Author keyword | 99 | 78% | 2% | 65 |
5 | BRADYKININ RECEPTORS | Author keyword | 87 | 75% | 2% | 63 |
6 | BRADYKININ B 2 RECEPTOR | Author keyword | 81 | 73% | 2% | 61 |
7 | DES ARG9 BRADYKININ | Author keyword | 72 | 81% | 2% | 43 |
8 | KININ RECEPTORS | Author keyword | 67 | 68% | 2% | 58 |
9 | KININS | Author keyword | 50 | 36% | 4% | 113 |
10 | KININ B 1 RECEPTOR | Author keyword | 47 | 86% | 1% | 24 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRADYKININ | 234 | 25% | 30% | 810 | Search BRADYKININ | Search BRADYKININ |
2 | B 1 RECEPTOR | 116 | 92% | 2% | 46 | Search B+1+RECEPTOR | Search B+1+RECEPTOR |
3 | BRADYKININ B 1 RECEPTOR | 109 | 92% | 2% | 44 | Search BRADYKININ+B+1+RECEPTOR | Search BRADYKININ+B+1+RECEPTOR |
4 | B 2 RECEPTOR | 99 | 78% | 2% | 65 | Search B+2+RECEPTOR | Search B+2+RECEPTOR |
5 | BRADYKININ RECEPTORS | 87 | 75% | 2% | 63 | Search BRADYKININ+RECEPTORS | Search BRADYKININ+RECEPTORS |
6 | BRADYKININ B 2 RECEPTOR | 81 | 73% | 2% | 61 | Search BRADYKININ+B+2+RECEPTOR | Search BRADYKININ+B+2+RECEPTOR |
7 | DES ARG9 BRADYKININ | 72 | 81% | 2% | 43 | Search DES+ARG9+BRADYKININ | Search DES+ARG9+BRADYKININ |
8 | KININ RECEPTORS | 67 | 68% | 2% | 58 | Search KININ+RECEPTORS | Search KININ+RECEPTORS |
9 | KININS | 50 | 36% | 4% | 113 | Search KININS | Search KININS |
10 | KININ B 1 RECEPTOR | 47 | 86% | 1% | 24 | Search KININ+B+1+RECEPTOR | Search KININ+B+1+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KININ RECEPTORS | 272 | 85% | 5% | 141 |
2 | KININS | 211 | 51% | 11% | 296 |
3 | DES ARG9 BRADYKININ | 183 | 87% | 3% | 91 |
4 | HOE 140 | 159 | 65% | 6% | 153 |
5 | B2 RECEPTOR | 128 | 81% | 3% | 77 |
6 | B 2 RECEPTOR | 110 | 61% | 4% | 115 |
7 | B 1 RECEPTORS | 108 | 78% | 3% | 71 |
8 | B 1 RECEPTOR | 97 | 82% | 2% | 56 |
9 | KININ B 1 | 89 | 84% | 2% | 48 |
10 | B1 RECEPTORS | 82 | 92% | 1% | 33 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences | 2005 | 454 | 506 | 73% |
The B-1 receptors for kinins | 1998 | 418 | 212 | 73% |
The role of kinin receptors in cancer and therapeutic opportunities | 2014 | 8 | 174 | 66% |
KININ B-1 RECEPTORS - A REVIEW | 1995 | 311 | 132 | 86% |
Kinin B-1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes | 2004 | 140 | 162 | 82% |
Kinins in pain and inflammation | 2000 | 158 | 29 | 79% |
Bradykinin receptors | 1997 | 126 | 27 | 100% |
Bradykinin receptors and their antagonists | 1998 | 169 | 69 | 88% |
BRADYKININ AND INFLAMMATORY PAIN | 1993 | 472 | 49 | 51% |
The kallikrein-kinin system: Current and future pharmacological targets | 2005 | 210 | 294 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP PHARMACOCHIM RECEPTEURS | 11 | 78% | 0.3% | 7 |
2 | GRP PEPTIDE BIOCHEM | 6 | 80% | 0.1% | 4 |
3 | U388 | 6 | 26% | 0.7% | 19 |
4 | MOL BIOL PEPTIDE HORMONES GRP | 6 | 100% | 0.1% | 4 |
5 | ESCUELA MED ODONTOL | 4 | 75% | 0.1% | 3 |
6 | RECH RHUMATOL IMMUNOL | 4 | 11% | 1.2% | 32 |
7 | HYPERTENS ATHEROSCLEROSIS SECT | 3 | 25% | 0.4% | 12 |
8 | EXPT MED GENE THER Y SECT | 3 | 50% | 0.1% | 4 |
9 | RECH PAVILLON HOTEL DIEU QUEBEC | 3 | 60% | 0.1% | 3 |
10 | CARDIOVASC MED GENE THER Y SECT | 2 | 44% | 0.1% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000226222 | HUMAN URINARY KALLIDINOGENASE SK 827//HYPERTENS DIABET UNIT//MUSCLE METAB |
2 | 0.0000184534 | KALLIKREIN//KALLISTATIN//RENAL KALLIKREIN KININ SYSTEM |
3 | 0.0000178037 | T KININOGEN//T KININ//M 5011 |
4 | 0.0000090706 | MANDEVILLA VELUTINA//STERCULIA GUTTATA//2 O RHAMNOSYLSWERTISIN |
5 | 0.0000063235 | BRADYKININ POTENTIATING PEPTIDE//RONDON COMMISSION//CARLOS CHAGAS |
6 | 0.0000054177 | FACTOR XII//FACTOR XI//FACTOR XI DEFICIENCY |
7 | 0.0000052395 | EP1 ANTAGONIST//VISCERAL NOCICEPTOR//POLYMODAL RECEPTOR |
8 | 0.0000044389 | MASTOPARAN//MASTOPARAN B//PEPTIDE BIOSIGNAL ENGN |
9 | 0.0000039319 | THIMET OLIGOPEPTIDASE//EP2415//NEUROLYSIN |
10 | 0.0000038651 | CL EXTRACELLULAR//RB 86 FLUX//RECEPTOR OPERATED CA2 CHANNEL |